Abstract
TRC105 is an anti-endoglin antibody currently being tested in combination with VEGF inhibitors. In the phase Ib trial, 38 patients were treated with both TRC105 and bevacizumab (BEV), and improved clinical outcomes were observed, despite the fact that 30 patients (79%) were refractory to prior anti-VEGF therapy. Plasma samples were tested for angiogenic and inflammatory biomarkers at baseline and on-treatment. To provide broader context of this combination biomarker study, direct cross-study comparisons were made to biomarker studies previously conducted in patients treated with either BEV or TRC105 monotherapy. Upon treatment with BEV and TRC105, pharmacodynamic changes in response to both BEV (PlGF increase) and TRC105 (soluble endoglin increase) were noted. In addition, distinct patterns of change were identified (similar, opposing, neutralizing). Similar patterns were observed when the combination elicited similar effects to those observed with monotherapy treatment (i.e., decreases of Ang-2, increases of IL6 and VCAM-1). Opposing patterns were observed when the combination led to opposing effects compared with monotherapy treatment (i.e., TGFβ1, PDGF-AA and PDGF-BB, PAI-1). Lastly, neutralizing patterns were observed when ...Continue Reading
References
Sep 7, 1995·Annals of the New York Academy of Sciences·K E BornfeldtR Ross
Sep 1, 1993·Journal of Neuro-oncology·J S RaoR Sawaya
Oct 7, 1998·International Journal of Cancer. Journal International Du Cancer·S K ChambersM L Carcangiu
Jul 2, 2004·The EMBO Journal·Jianying DongNapoleone Ferrara
Jul 3, 2004·Cancer Research·Darren W DavisDavid J McConkey
May 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Max L TejadaNapoleone Ferrara
Jul 4, 2007·Journal of Translational Medicine·Samuel E DeprimoRobert J Motzer
Jan 23, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J Seoane
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G WillettRakesh K Jain
Apr 29, 2010·Cancer Research·Lukas J A C HawinkelsPeter ten Dijke
Sep 28, 2010·Blood Reviews·Claire L Shovlin
Nov 3, 2010·Current Drug Delivery·Ben K SeonYuro Haruta
Mar 31, 2012·Atherosclerosis·Petr NachtigalZbynek Strasky
Apr 7, 2012·Journal of Oncology·Han Chung ChongNguan Soon Tan
Jul 7, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lee S RosenMichael S Gordon
Jan 10, 2013·PloS One·Olivier Nolan-StevauxAstrid Ruefli-Brasse
Feb 13, 2013·The Journal of Experimental Medicine·Charlotte AnderbergKristian Pietras
May 2, 2013·Cancer Medicine·Yingmiao LiuAndrew B Nixon
Oct 8, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew B NixonUNKNOWN Alliance for Clinical Trials In Oncology
Oct 22, 2013·PloS One·Christopher H LieuScott Kopetz
Nov 21, 2013·Placenta·A L GregoryM Letarte
Jan 22, 2014·Current Oncology Reports·Lee S RosenDaniela E Matei
Feb 28, 2014·Cancer Medicine·Yingmiao LiuAndrew B Nixon
Sep 28, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael S GordonLee S Rosen
Nov 20, 2014·BJU International·Fatima H KarzaiWilliam L Dahut
Feb 20, 2015·Molecular Cancer Therapeutics·Yingmiao LiuAndrew B Nixon
Citations
Sep 10, 2019·The Prostate·Daniel J GeorgeAndrew J Armstrong
May 27, 2020·Cancer·Richard D KimDae Won Kim
Aug 25, 2019·Cancer Chemotherapy and Pharmacology·Jeffrey Melson ClarkeHerbert I Hurwitz
Aug 5, 2020·Molecular Cancer Therapeutics·Yingmiao LiuAndrew B Nixon
Apr 26, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark J A SchoonderwoerdLukas J A C Hawinkels
Dec 31, 2020·International Journal of Molecular Sciences·Yingmiao LiuLukas J A C Hawinkels
Apr 3, 2021·Developmental Dynamics : an Official Publication of the American Association of Anatomists·John B Pawlak, Gerard C Blobe
Feb 18, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew J ArmstrongSusan Halabi